Evidence map›Paper›PMID 33737031›Full record

ArticleAmerican journal of ophthalmology2021

KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints-KCNV2 Study Group Report 2.

Michalis Georgiou, Kaoru Fujinami, Ajoy Vincent, Fadi Nasser, Samer Khateb, Mauricio E Vargas, Alberta A H J Thiadens, Emanuel R de Carvalho, Xuan-Thanh-An Nguyen, Thales Antônio Cabral De Guimarães and 27 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in American journal of ophthalmology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Retinal Sensitivity Loss and Beyond inTurkish journal of ophthalmology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Retinal Sensitivity in KCNV2-Associated Retinopathy.Investigative ophthalmology & visual science · 2025
    Article
  10. Article
  11. Article
  12. The British journal of ophthalmology · 2024
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 13 institutions in 8 countries.

Michalis GeorgiouMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Kaoru FujinamiMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom; Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center; Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Ajoy VincentDepartment of Ophthalmology and Vision Sciences, the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Fadi NasserInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Samer KhatebInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany; Department of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Mauricio E VargasDepartment of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA.
Alberta A H J ThiadensDepartment of Ophthalmology, Erasmus Medical Center, Rotterdam.
Emanuel R de CarvalhoMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom; Department of Ophthalmology, Amsterdam UMC, Academic Medical Center, Amsterdam.
Xuan-Thanh-An NguyenDepartment of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
Thales Antônio Cabral De GuimarãesMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Anthony G RobsonMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Omar A MahrooMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Nikolas PontikosMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Gavin ArnoMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Yu Fujinami-YokokawaMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom; Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center; Department of Health Policy and Management, Keio University School of Medicine.
Shaun Michael LeoMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Xiao LiuLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center.
Kazushige TsunodaLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center.
Takaaki HayashiDepartment of Ophthalmology, Katsushika Medical Center, The Jikei University School of Medicine Tokyo, Japan.
Belen Jimenez-RolandoDepartment of Ophthalmology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Maria Inmaculada Martin-MeridaDepartment of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM); Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Almudena Avila-FernandezDepartment of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM); Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Ester CarreñoDepartment of Ophthalmology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Blanca Garcia-SandovalDepartment of Ophthalmology, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Carmen AyusoDepartment of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital-Universidad Autónoma de Madrid (IIS-FJD, UAM); Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Dror SharonDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Susanne KohlInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Rachel M HuckfeldtDepartment of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
Camiel J F BoonDepartment of Ophthalmology, Amsterdam UMC, Academic Medical Center, Amsterdam; Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
Eyal BaninDepartment of Ophthalmology, Hadassah Medical Center, Faculty of Medicine, the Hebrew University of Jerusalem, Jerusalem, Israel.
Mark E PennesiDepartment of Ophthalmology, Oregon Health & Science University, Casey Eye Institute, Portland, Oregon, USA.
Bernd WissingerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Andrew R WebsterMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom.
Elise HéonDepartment of Ophthalmology and Vision Sciences, the Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Arif O KhanEye Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates; Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine of Case Western University, Cleveland, Ohio, USA.
Eberhart ZrennerInstitute for Ophthalmic Research, Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Michel MichaelidesMoorfields Eye Hospital, 162 City Rd, London EC1V 2PD, United Kingdom; UCL Institute of Ophthalmology, University College London, 11-43 Bath St, London EC1V 9E, United Kingdom. Electronic address: michel.michaelides@ucl.ac.uk.
Moorfields Eye Hospital NHS Foundation Trust · GBSTZ eyetrial · DEHebrew University of Jerusalem · ILHospital Universitario Fundación Jiménez Díaz · ESInstituto de Salud Carlos III · ESLeiden University Medical Center · NLOregon Health & Science University · USTokyo Medical Center · JPUniversity of Toronto · CACleveland Clinic Lerner College of Medicine · USErasmus MC · NLJikei University School of Medicine · JPMassachusetts Eye and Ear Infirmary · US

Funding

Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Kate E Keller · 1995 to 2026
$19.4M
Department of HealthNEI NIH HHS P30 EY010572Wellcome TrustWellcome Trust 099173/Z/12/ZWellcome Trust 206619/Z/17/Z
6 · The paper itself

Abstract

purposeTo describe the detailed retinal phenotype of KCNV2-associated retinopathy. STUDY

designMulticenter international retrospective case series.

methodsReview of retinal imaging including fundus autofluorescence (FAF) and optical coherence tomography (OCT), including qualitative and quantitative analyses.

resultsThree distinct macular FAF features were identified: (1) centrally increased signal (n = 35, 41.7%), (2) decreased autofluorescence (n = 27, 31.1%), and (3) ring of increased signal (n = 37, 44.0%). Five distinct FAF groups were identified based on combinations of those features, with 23.5% of patients changing the FAF group over a mean (range) follow-up of 5.9 years (1.9-13.1 years). Qualitative assessment was performed by grading OCT into 5 grades: (1) continuous ellipsoid zone (EZ) (20.5%); (2) EZ disruption (26.1%); (3) EZ absence, without optical gap and with preserved retinal pigment epithelium complex (21.6%); (4) loss of EZ and a hyporeflective zone at the foveola (6.8%); and (5) outer retina and retinal pigment epithelium complex loss (25.0%). Eighty-six patients had scans available from both eyes, with 83 (96.5%) having the same grade in both eyes, and 36.1% changed OCT grade over a mean follow-up of 5.5 years. The annual rate of outer nuclear layer thickness change was similar for right and left eyes.

conclusionsKCNV2-associated retinopathy is a slowly progressive disease with early retinal changes, which are predominantly symmetric between eyes. The identification of a single OCT or FAF measurement as an endpoint to determine progression that applies to all patients may be challenging, although outer nuclear layer thickness is a potential biomarker. Findings suggest a potential window for intervention until 40 years of age.

Indexed as

Potassium Channels, Voltage-GatedRetinal DiseasesFluorescein AngiographyFundus OculiHumansPhenotypeRetinaRetrospective StudiesTomography, Optical CoherenceKCNV2 protein, humanPotassium Channels, Voltage-Gated

Identifiers

PMID33737031
PMCPMC8710866
OpenAlexW3136527718

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.